IronBridge Capital Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

IronBridge Capital Management’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-182,410	Closed	-$3.03M	–	192
2015 Q3	$3.03M	Buy	182,410 +35,170	+24%	+$705K	0.12%	142
2015 Q2	$3.31M	Buy	147,240 +7,400	+5%	+$182K	0.1%	146
2015 Q1	$3.6M	Sell	139,840 -7,720	-5%	-$196K	0.1%	149
2014 Q4	$3.21M	Buy	+147,560	New	+$3.02M	0.09%	162

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

IronBridge Capital Management's OMED Position: Q4 2015 in Review

IronBridge Capital Management sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2015, closing a stake of 182,410 shares — an estimated $3.03M sold.

IronBridge Capital Management first reported a position in OMED in Q4 2014 and held it in 4 quarters. The position peaked at $3.6M in Q1 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q4 2015.

IronBridge Capital Management reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
IronBridge Capital Management sold 182,410 OncoMed Pharmaceuticals, Inc. shares in Q4 2015, an estimated $3.03M.
IronBridge Capital Management first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2014 and held it in 4 quarters.
IronBridge Capital Management's OncoMed Pharmaceuticals, Inc. position peaked at $3.6M in Q1 2015.
83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2015.

Based on IronBridge Capital Management's 13F filing for Q4 2015, filed 8 Feb 2016.